Independent Advisor Alliance’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,996
| Closed | -$212K | – | 550 |
|
|
2022
Q3 | $212K | Sell |
1,996
-398
| -17% | -$42.3K | 0.01% | 569 |
|
|
2022
Q2 | $233K | Sell |
2,394
-394
| -14% | -$38.3K | 0.01% | 540 |
|
|
2022
Q1 | $261K | Sell |
2,788
-353
| -11% | -$33K | 0.01% | 534 |
|
|
2021
Q4 | $268K | Sell |
3,141
-505
| -14% | -$43.1K | 0.01% | 549 |
|
|
2021
Q3 | $350K | Sell |
3,646
-574
| -14% | -$55.1K | 0.02% | 451 |
|
|
2021
Q2 | $411K | Buy |
4,220
+16
| +0.4% | +$1.56K | 0.02% | 435 |
|
|
2021
Q1 | $409K | Buy |
4,204
+6
| +0.1% | +$584 | 0.02% | 411 |
|
|
2020
Q4 | $402K | Buy |
4,198
+35
| +0.8% | +$3.35K | 0.03% | 386 |
|
|
2020
Q3 | $400K | Buy |
4,163
+941
| +29% | +$90.4K | 0.03% | 336 |
|
|
2020
Q2 | $393K | Buy |
+3,222
| New | +$393K | 0.04% | 316 |
|